Tempus AI Inc. (TEM)
Tempus AI Inc. (TEM) Stock Price, Analysis & Data
| Bid | 51.3 |
| Market Cap | 9.79B |
| Revenue (ttm) | 1.43B |
| Net Income (ttm) | -254.42M |
| Beta | 3.58 |
| EPS (ttm) | -1.44 |
| PE Ratio (ttm) | n/a |
| Forward PE | -3569.74 |
| P/B (ttm) | 21.96 |
| P/S (ttm) | 6.84 |
| Earnings Date | Nov 3, 2026 |
| Ask | 58.62 |
| Volume | 2,190,423 |
| Avg. Volume (20D) | 6,100,806 |
| Open | 56.00 |
| Previous Close | 55.69 |
| Day's Range | 54.15 - 57.03 |
| 52-Week Range | 40.77 - 104.32 |
| Analyst | Buy |
| Price Target | 59 (8.74%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About TEM
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for he...
Financial Performance
In 2025, Tempus AI's revenue was 1.27B, an increase of 83.41% compared to the previous year's 693.4M. Earnings were -245.03M, a decrease of -65.28%.
Financial StatementsAnalyst Forecast
According to 14 analyst ratings, the average rating for TEM stock is "Buy". The 12-month stock price forecast is 59, which is upside of 8.74% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
